Search For "trials"
HIV vaccine efforts are undermined by off-target antibodies
Updated : 4 years, 8 months ago IST
California [US], July 29 (ANI): Some proof-of-concept HIV vaccines in early human trials generate antibodies that actively hinder protection by degrading the vaccine's payload, suggests a new study from Scripps Research.
Read More
COVID-19 vaccine manufacturing firms being encouraged to conduct paediatri
Updated : 4 years, 8 months ago IST
New Delhi [India], July 27 (ANI): After trials on adults, COVID-19 vaccine manufacturing companies Biological E and Novavax are being encouraged to conduct a study on paediatrics, said Member-Health of NITI Aayog Dr VK Paul on Tuesday.
Read More
Biological E's COVID-19 vaccine Corbevax likely to be launched by Septembe
Updated : 4 years, 8 months ago IST
New Delhi [India], July 26 (ANI): The Hyderabad-based pharmaceutical company Biological E is expected to launch its COVID-19 vaccine Corbevax by September end in India, said sources on Monday.
Read More
COVAXIN trial results on children likely by September: AIIMS chief Dr Rand
Updated : 4 years, 8 months ago IST
New Delhi [India], July 24 (ANI): Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria informed.
Read More
US sanctions Cuban officials over crackdown on protests
Updated : 4 years, 8 months ago IST
Washington DC [US], July 23 (ANI): The United States on Friday condemned "mass detentions and sham trials" in Cuba and announced sanctions on the Cuban military and its Interior Ministry against the ongoing crackdown on the civilian population on the island.
Read More
COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week
Updated : 4 years, 8 months ago IST
New Delhi [India], July 23 (ANI): As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday.
Read More
Optimus announces Interim Clinical Results from Phase III Clinical Trials
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients.
Read More
LG dismisses lawyers panel suggested by Delhi govt's for cases linked to f
Updated : 4 years, 8 months ago IST
New Delhi [India], July 16 (ANI): The Delhi government on Thursday said that Lieutenant Governor Anil Baijal has rejected the panel of lawyers constituted by it to appear in trials of the cases linked to farmers' protest.
Read More
Hetero announces interim clinical results from Phase III clinical trials o
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 9 (ANI): Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from Phase III clinical trials of Molnupiravir in mild Covid-19 patients conducted across multiple COVID-19 dedicated h
Read More
Glenmark to conduct phase III trials of nasal spray it claims to be effect
Updated : 4 years, 8 months ago IST
New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of COVID-19.
Read More
Don't need Phase 3 trials, Sputnik Light vaccine can submit Russian safety
Updated : 4 years, 9 months ago IST
New Delhi [India], July 1 (ANI): Sputnik vaccine's India-partner Dr Reddy's on Thursday informed that the government panel has told the pharma firm that it does not need to conduct Phase 3 trials for Sputnik Light and only require to submit Russian safety data for approval in India.
Read More
'Submit results on Covavax adult trials first': Govt panel to SII on Covid
Updated : 4 years, 9 months ago IST
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sources on
Read More